GSIE - ETF AI Analysis
Top Page
Goldman Sachs ActiveBeta International Equity ETF (GSIE)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the past few months, showing positive momentum.
Well-Performing Top Holdings
Several of the largest positions, including major semiconductor, banking, and pharmaceutical companies, have shown strong or steady performance, supporting the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries and sectors, which helps reduce the impact of problems in any single market or industry.
Negative Factors
Moderate Expense Ratio
While not extremely high, the fund’s fees are higher than the cheapest index ETFs, which slightly reduces net returns over time.
Financial Sector Sensitivity
A sizable allocation to financial companies means the fund could be more affected if banks or financial markets face stress.
Mixed Performance Among Top Holdings
Although many top holdings are performing well, at least one major position has been weak, which can drag on overall results if that continues.
GSIE vs. SPDR S&P 500 ETF (SPY)
AUM6.02B
RegionDeveloped Markets
Expense Ratio0.25%
Beta0.71
IssuerGoldman Sachs
Inception DateNov 06, 2015
Dividend Yield2.51%
Asset ClassEquity
Index TrackedStuttgart Goldman Sachs ActiveBeta Intl.Equity (USD)
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume291,794
30 Day Avg. Volume392,228
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
55.64Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering630
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GSIE Summary
GSIE is the Goldman Sachs ActiveBeta International Equity ETF, which follows the Stuttgart Goldman Sachs ActiveBeta International Equity index and invests in stocks from many countries outside the U.S., like Japan, the UK, and Europe. It holds a wide mix of sectors, including financials, industrials, and healthcare, with well-known companies such as ASML Holding, Royal Bank of Canada, HSBC, Novartis, and AstraZeneca. Investors might consider GSIE to diversify beyond the U.S. and seek long-term growth from global markets. A key risk is that international stocks can go up and down with global market and currency swings.
How much will it cost me?The expense ratio for the Goldman Sachs ActiveBeta International Equity ETF (GSIE) is 0.25%, which means you’ll pay $2.50 per year for every $1,000 invested. This is lower than average for actively managed ETFs because it uses a factor-based strategy rather than traditional stock-picking, keeping costs relatively modest.
What would affect this ETF?The GSIE ETF, with its focus on developed markets outside the U.S., could benefit from economic growth in Europe and Asia, particularly if industries like financials and technology, which have significant weight in the fund, experience expansion. However, it may face challenges from rising interest rates or geopolitical tensions that could negatively impact international markets and sectors like financials and consumer cyclical. Additionally, regulatory changes in key regions or currency fluctuations could influence the ETF's performance.
GSIE Top 10 Holdings
GSIE’s story is driven by a mix of global heavyweights, with a clear tilt toward non-U.S. financials, health care, and tech. ASML and Advantest are rising stars, giving the fund a strong semiconductor backbone, while Recruit Holdings has been sprinting ahead and adding momentum from Japan. On the defensive side, big banks like HSBC, Royal Bank of Canada, and Banco Santander are steady contributors, though not explosive. AstraZeneca, however, has been losing steam lately, slightly dragging on performance. Overall, it’s a diversified developed-markets ex-U.S. play with a subtle growth edge.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.14% | $128.49M | €533.33B | 78.59% | 76 Outperform | |
| HSBC Holdings | 1.16% | $69.64M | £258.64B | 49.58% | 80 Outperform | |
| Royal Bank Of Canada | 1.12% | $67.04M | $280.64B | 39.28% | 75 Outperform | |
| Roche Holding AG | 1.04% | $62.12M | $350.70B | 35.40% | 73 Outperform | |
| Novartis AG | 0.92% | $55.03M | CHF209.20B | 19.98% | 80 Outperform | |
| Banco Santander | 0.90% | $53.87M | €184.52B | 50.27% | 73 Outperform | |
| Advantest | 0.85% | $51.04M | ¥21.42T | 137.02% | 75 Outperform | |
| Toronto Dominion Bank | 0.82% | $49.17M | $203.92B | 55.37% | 74 Outperform | |
| Recruit Holdings Co | 0.79% | $47.22M | ¥23.29T | 105.07% | 67 Neutral | |
| AstraZeneca | 0.75% | $45.13M | $251.48B | 10.49% | 80 Outperform |
GSIE Technical Analysis
Neutral
―
Price Trends
47.29
Negative
46.21
Positive
44.83
Positive
Market Momentum
-0.12
Positive
41.99
Neutral
23.17
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSIE, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 47.69, equal to the 50-day MA of 47.29, and equal to the 200-day MA of 44.83, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 41.99 is Neutral, neither overbought nor oversold. The STOCH value of 23.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GSIE.
GSIE Peer Comparison
Comparison Results
Performance Comparison
GSIE
Goldman Sachs ActiveBeta International Equity ETF
46.87
6.53
16.19%
LVHI
Legg Mason International Low Volatility High Dividend ETF
―
―
―
IDMO
Invesco S&P International Developed Momentum ETF
―
―
―
IMTM
iShares MSCI Intl Momentum Factor ETF
―
―
―
INTF
iShares MSCI Intl Multifactor ETF
―
―
―
PXF
Invesco FTSE RAFI Developed Markets ex-U.S. ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents